| Ytd | 8.99% | |
| 1y | 194.21% |
| Open | 18.94 | Prev Close | 18.99 | Low | 18.80 | High | 19.30 | Mkt Cap | 1.79B |
| Vol | 23.22K | Avg Vol | 1.44M | EPS | 0.56 | P/E | 33.57 | Forward P/E | 16.18 |
| Beta | 1.99 | Short Ratio | 7.18 | Inst. Own | 110.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 17.52 | 200-d Avg | 13.90 | 1yr Est | 20.55 |
TD Cowen analyst Charles Rhyee maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises the
Citigroup analyst Brendan Digan maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises th
Fortrea Holdings Inc. (FTRE) might move higher on growing optimism about its earnings prospects, whi
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Fortrea Ho
FTRE, ASML and KLAC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 31, 2026.
Fortrea Holdings Inc. (FTRE) could be a great choice for investors looking to buy stocks that have g
Truist Securities analyst Jailendra Singh maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and
Evercore ISI Group analyst Elizabeth Anderson maintains Fortrea Holdings (NASDAQ:FTRE) with a Out
Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and ra
Fortrea Holdings Inc. (FTRE) Q2 2026 Earnings Call Transcript
Fortrea NASDAQ: FTRE reported second-quarter 2026 revenue of $678.2 million and adjusted EBITDA of $
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.23 per share, beating the Zacks
Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.23 per share which beat the analyst
Fortrea Holdings (NASDAQ:FTRE) raises FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.
Four consecutive quarters of execution to drive commercial, operational and financial excellence Inc
PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigati
DURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading gl
Mizuho analyst Ann Hynes maintains Fortrea Holdings (NASDAQ:FTRE) with a Neutral and raises the p
Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market l
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably alrea
DEC, FTRE, HG, PARR and KE have been added to the Zacks Rank #1 (Strong Buy) List on July 7, 2026.
2026 Financial GuidanceThe Company reiterates its guidance for the full year 2026, targeting revenue
Fortrea (NASDAQ:FTRE) (the "Company"), a leading global contract research organization (CRO)
Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea Jason Knoblauch wi
Top Wall Street analysts changed their outlook on top names. See all analyst rating changes, includi
Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and ra
DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading gl
DURHAM, N. C. , June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract
Mizuho analyst Ann Hynes maintains Fortrea Holdings (NASDAQ:FTRE) with a Neutral and raises the p
Citigroup analyst Patrick Donnelly maintains Fortrea Holdings (NASDAQ:FTRE) with a Buy and raises
Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and ra
Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.16 per share, beating the Zacks
Fortrea Holdings (NASDAQ:FTRE) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2
Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.16 per share which beat the analyst
Strong first-quarter performance reinforces confidence in FY 2026 guidance Book-to-bill of 1.15x is
Evercore ISI Group analyst Elizabeth Anderson maintains Fortrea Holdings (NASDAQ:FTRE) with a Out
TD Cowen analyst Charles Rhyee upgrades Fortrea Holdings (NASDAQ:FTRE) from Hold to Buy and annou
Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and lo
Baird analyst Eric Coldwell maintains Fortrea Holdings (NASDAQ:FTRE) with a Outperform and lowers
Fortrea Holdings (NASDAQ:FTRE) sees FY2026 sales of $2.550 billion-$2.650 billion vs $2.736 billion
Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.09 per share which missed the analy